Legislation – The Human Medicines (Amendments Relating to Coronavirus and Influenza) Regulations (Northern Ireland) 2024

New Search

Introduction

1 Citation, commencement and extent

2 Amendment of the Human Medicines Regulations 2012

3 Amendment of regulation 3A

4 Amendment of regulation 19

5 Amendment of regulation 247A

Signature

Explanatory note

Changes to legislation:

There are currently no known outstanding effects for The Human Medicines (Amendments Relating to Coronavirus and Influenza) Regulations (Northern Ireland) 2024, Introductory Text. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

2024 No. 68
Medicines

The Human Medicines (Amendments Relating to Coronavirus and Influenza) Regulations (Northern Ireland) 2024

Laid before Assembly in draft
Made
Coming into force in accordance with regulation 1(2)
The Department of Health, makes the following Regulations in exercise of the powers conferred by sections 2(1), 3(1)(a) to (d), (h), (j) and (n) and (2)(a) and (c), 6(1)(b) and 43(2) of the Medicines and Medical Devices Act 20211.

The Department of Health has carried out a public consultation in accordance with section 45(1) of that Act.

In accordance with section 2(2) to (4) of that Act, the Department of Health’s overarching objective in making these Regulations is safeguarding public health, the Department of Health has had regard to the matters specified in section 2(3) of that Act and considers that, where these Regulations may have an impact on the safety of human medicines, the benefits of making these Regulations outweigh the risks.

In accordance with section 47(2), (3) and (6)(b) of that Act, a draft of these Regulations has been laid before, and approved by resolution of the Assembly.

1

2021 c. 3. The powers in section 2(1) of the Medicines and Medical Devices Act 2021, and in the provisions that relate to it, are exercisable by the “appropriate authority”. See section 2(6) of that Act, which contains the definition of “appropriate authority” that is relevant to the powers being exercised.